Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH antagonist pituitary suppression during medicated frozen-thawed embryo transfer
2018-001915-63Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Mar 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cetrorelix in female infertility (2 arms), sponsored by University of Oxford. Primary endpoint: Livebirth rate per embryo transfer procedure. Status: unknown.
02
Drugs
cetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on 2018-001915-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001915-63.